Device and method for internal surface sclerostomy
AssigneeUniversity of Michigan
InventorsTibor Juhasz, Zachary S. Sacks, Ronald M. Kurtz, Gerard A. Mourou
Life of this patent
Estimating the term…
Loading patent…
AssigneeUniversity of Michigan
InventorsTibor Juhasz, Zachary S. Sacks, Ronald M. Kurtz, Gerard A. Mourou
Estimating the term…
An ab interno method for transscleral photodisruption of tissue on the interior surface of the sclera includes selecting a wavelength for a laser beam. The selected wavelength may be either from a first range of wavelengths (0.4-1.4 .mu.m) which is normally strongly scattered as it is transmitted through the sclera, or from a second range of longer wavelengths (1.5-2.5 .mu.m) which is less scattered as it is transmitted through the sclera. If the first range of wavelengths is selected, a chemical agent may be applied to the sclera to make it effectively transparent, but this may not be necessary. In either case, the laser beam is focused directly through the sclera to a focal point on the interior surface of the sclera. Once focused, the laser beam is activated to photodisrupt scleral tissue at the focal point. The laser beam is then moved in a pattern and refocused at successive focal points to photodisrupt scleral tissue at each of the focal points. This continues until the desired volume of scleral tissue has be photodisrupted, and thereby removed, from the interior surface of the sclera. The use of ultrashort laser pulses (in the femtosecond or picosecond range) is advantageous in order to achieve high precision and avoid collateral tissue damage. Such collateral damage is known to cause unwanted healing effects which are known to result in surgical failure.
An ab interno method for transscleral photodisruption of tissue in the sclera or limbus which comprises the steps of:
A method for photodisruption of scleral tissue which comprises the steps of:
Dependencies are inferred from the claim text.